Another Chinese drugs official is to stand trial on bribery charges as the country continues its crackdown on corruption within its healthcare system.

China’s official Xinhua News Agency reports a story from the Beijing Times which notes that the public procurators’ office has filed a document with the Xicheng District Court against Liu Yongjiu, who stands accused of taking bribes to the tune of 100,000 yuan, or around $13,000. Liu is a former deputy secretary general of the China Pharmaceutical Association (CPA), a non-profit organisation for pharmacists, and the document filed with the court claims that he took money from an advertising company and a pharmaceutical manufacturer.

Liu, who the newspaper says is in his forties, has been under investigation since last November and it is not known when his trial will begin, though it will be in Beijing. He is the latest among a host of officials who have been punished or are under investigation for their alleged wrong-doings in the drug sector, Xinhua states.

In July, Zheng Xiaoyu, the former director of China’s State Food and Drug Administration, and an ex-president of the executive council of the CPA, was executed for taking around $850,000 in bribes and dereliction of duty. During his tenure the SFDA approved six medicines that turned out to be fake, and one antibiotic caused the deaths of at least 10 people.

Others punished include Cao Wenzhuang, the former drug registration division chief of the SFDA, who received a suspended death sentence in August after taking bribes worth some $316,000. Also, Lu Aiying, an assistant supervisor with Cao's division, was sentenced to 14 years in jail, while Wang Guorong, the former deputy secretary general of China Pharmacopoeia Committee, received life imprisonment.